KR101176892B1 - Method of preparing methylgerambullone and intermediates therefor - Google Patents
Method of preparing methylgerambullone and intermediates therefor Download PDFInfo
- Publication number
- KR101176892B1 KR101176892B1 KR1020080011647A KR20080011647A KR101176892B1 KR 101176892 B1 KR101176892 B1 KR 101176892B1 KR 1020080011647 A KR1020080011647 A KR 1020080011647A KR 20080011647 A KR20080011647 A KR 20080011647A KR 101176892 B1 KR101176892 B1 KR 101176892B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- methyl
- group
- methylsulfonyl
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/06—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 운향과의 글리코스미스 앙구스티폴리아(Glycosmis angustifolia)의 잎으로부터 추출에 의해 얻었던 메틸제람블론을 용이하게 고수율 및 고순도로 제조하는 방법, 이를 위한 신규한 중간체, 및 이들 중간체의 제조방법에 관한 것이다. The present invention relates to a method for easily preparing high yield and high purity of methylzelamblon obtained by extracting from the leaves of Glycosmis angustifolia with the fragrance , a novel intermediate for this, and a method for preparing these intermediates. It is about.
메틸제람블론, 제조방법, 중간체 Methylzelamblon, preparation method, intermediate
Description
본 발명은 메틸제람블론의 제조방법 및 이를 위한 중간체에 관한 것이다. 보다 구체적으로, 본 발명은 메틸제람블론을 용이하게 고수율 및 고순도로 제조하는 방법, 이를 위한 중간체, 및 이들 중간체의 제조방법에 관한 것이다. The present invention relates to a method for preparing methylzelamblon and an intermediate for the same. More specifically, the present invention relates to a method for easily preparing methylzelamblon in high yield and high purity, intermediates for the same, and a method for preparing these intermediates.
메틸제람블론은 하기 화학식 1의 구조를 갖는 화합물로서, 운향과의 일종인 글리코스미스 앙구스티폴리아(Glycosmis angustifolia)의 잎으로부터 추출에 의해 얻을 수 있는 것으로 알려져 있다. Methylzelamblon is a compound having the structure of Formula 1, and is known to be obtained by extraction from the leaves of Glycosmis angustifolia , which is a kind of fragrance .
[화학식 1][Formula 1]
예를 들어, 참고문헌 [Liebigs Annalen , No 10, p 1789, 1995]에 따르면 태국에 있는 몇 가지 글리코스미스(Glycosmis) 종의 나뭇잎으로부터 5종의 메틸설포 닐 프로펜산 아미드를 분리할 수 있었고, 이들은 모두 펜에틸아미드 군을 포함하고 있으며, 그 가운데 하나가 메틸제람블론이었다. 한편, 참고문헌[Phytochemistry, Vol. 28, No. 3, p 1305, 1994]에 따르면, 스리랑카의 글리코스미스 앙구스티폴리아(Glycosmis angustifolia)의 나뭇잎으로부터 메탄올 추출방법에 의하여 메틸설폰프로펜산 아미드 유도체인 일곱 가지의 새로운 설폰 화합물을 분리하였으며, 이 중에 메틸제람블론, 메틸담블린 등이 포함되어 있다. 이 중 주성분인 메틸담블린은 어느 정도의 항균 효과를 나타냄이 밝혀져 있으며, 메틸제람블론 역시 항균 또는 위장관 운동에 효과가 있을 것으로 기대된다. For example, reference [ Liebigs Annalen , No 10, p 1789, 1995] were able to isolate five methylsulfonyl propene amides from the leaves of several Glycosmis species in Thailand, all of which contained the phenethylamide group. One of which was methylzelamblon. Meanwhile, references [ Phytochemistry , Vol. 28, No. 3, p 1305, 1994], seven new sulfone compounds, methylsulfonepropene amide derivatives, were isolated from the leaves of Glycosmis angustifolia in Sri Lanka by methanol extraction. Blon, methyldambulin and the like. Methyldamblin, the main component, has been shown to exhibit some degree of antimicrobial effect, and methylzelamblon is also expected to be effective in antibacterial or gastrointestinal motility.
그러나, 메틸제람블론을 추출방법으로 제조하는 것은 수율 및 순도가 극히 낮아 추가의 연구를 진행하기 어려운 문제점을 가지고 있었다. 따라서, 메틸제람블론을 고수율 및 고순도로 제조할 수 있는 방법의 개발이 절실히 요구되어 왔으나, 구조가 복잡하여 아직까지 메틸제람블론의 합성에 관하여 보고된 예는 없다. However, the preparation of methylzelamblon by the extraction method has a problem that it is difficult to proceed further research because the yield and purity is extremely low. Therefore, there has been a great demand for the development of a method capable of producing methylzelamblon with high yield and high purity, but the structure is complicated and there are no examples reported for the synthesis of methylzelamblon.
본 발명자들은 메틸제람블론의 합성 방법을 개발하기 위해 예의 연구 검토한 결과, 특정 중간체들을 이용하여 메틸제람블론을 고수율 및 고순도로 제조할 수 있음을 발견하고 본 발명을 완성하게 되었다. The present inventors have conducted extensive studies to develop a method for synthesizing methylzelamblon. As a result, the inventors have found that methylzelamblon can be produced in high yield and high purity using specific intermediates.
따라서, 본 발명의 목적은 메틸제람블론을 용이하게 고수율 및 고순도로 제조하는 방법을 제공하는 것이다. Accordingly, it is an object of the present invention to provide a method for producing methylzelamblon with high yield and high purity easily.
본 발명의 다른 목적은 메틸제람블론의 제조를 위한 신규한 특정 중간체들을 제공하는 것이다. Another object of the present invention is to provide certain new intermediates for the preparation of methylzelamblon.
본 발명의 또 다른 목적은 상기 중간체들을 제조하는 방법을 제공하는 것이다. Another object of the present invention is to provide a method for preparing the intermediates.
본 발명은 메틸제람블론을 용이하게 고수율 및 고순도로 제조하는 방법, 이를 위한 중간체, 및 이들 중간체의 제조방법에 관한 것이다. The present invention relates to a process for easily preparing methylzelamblon in high yield and high purity, intermediates for the same, and a process for preparing these intermediates.
본 발명의 메틸제람블론의 제조방법은 Method for producing methyl zelamblon of the present invention
(i) 하기 화학식 2의 4-(2-메틸아미노에틸)페놀과 하기 화학식 3의 3-(메틸설포닐)아크릴산을 결합 반응시켜 하기 화학식 5의 N-(4-히드록시펜에틸)-N-메틸-3-(메틸설포닐)아크릴아미드를 수득하는 단계;(i) for formula (2) of 4- (2-aminoethyl) phenol to 4- (methylsulfonyl) of formula (3) was coupled to the reaction of acrylic acid of formula 5 N - (4-hydroxy-phenethyl) - N Obtaining -methyl-3- (methylsulfonyl) acrylamide;
(ii) 상기 단계 (i)에서 수득한 하기 화학식 5의 N-(4-히드록시펜에틸)-N-메틸-3-(메틸설포닐)아크릴아미드와 하기 화학식 4의 화합물을 결합 반응시켜 하기 화학식 9의 (E)-N-메틸-N-[4-{(E)-3-메틸-4-(2-(2-메틸프로프-1-엔일)-1,3-[디치안]-2-일)부트-2-엔일옥시}펜에틸]-3-(메틸설포닐)아크릴아미드를 수득하는 단계; 및(ii) the reaction of N- (4-hydroxyphenethyl) -N -methyl-3- (methylsulfonyl) acrylamide of the formula (5) obtained in step (i) with the compound of formula (4) ( E ) -N -methyl- N- [4-{( E ) -3-methyl-4- (2- (2-methylprop-1-enyl) -1,3- [dician] of Formula 9 -2-yl) but-2-enyloxy} phenethyl] -3- (methylsulfonyl) acrylamide; And
(iii) 상기 단계 (ii)에서 수득한 하기 화학식 9의 (E)-N-메틸-N-[4-{(E)-3-메틸-4-(2-(2-메틸프로프-1-엔일)-1,3-[디치안]-2-일)부트-2-엔일옥시}펜에틸]-3-(메틸설포닐)아크릴아미드를 탈보호 반응시키는 단계를 포함한다.(iii) ( E ) -N -methyl- N- [4-{( E ) -3-methyl-4- (2- (2-methylprop-1) of formula (9) obtained in step (ii): Deprotection reaction of -enyl) -1,3- [dioxy] -2-yl) but-2-enyloxy} phenethyl] -3- (methylsulfonyl) acrylamide.
[화학식 1][Formula 1]
[화학식 2] [Formula 2]
[화학식 3] (3)
[화학식 4] [Formula 4]
[화학식 5] [Chemical Formula 5]
[화학식 9] [Chemical Formula 9]
상기 화학식 4에서, X는 히드록시기 또는 이탈기이다. 상기 이탈기로서는 클로라이드, 브로마이드, 메실, 또는 토실기가 바람직하다. In Formula 4, X is a hydroxy group or leaving group. As the leaving group, a chloride, bromide, mesyl, or tosyl group is preferable.
상기 단계 (i)에서 사용되는 화학식 2의 4-(2-메틸아미노에틸)페놀은 티라민을 메틸화 반응시켜 수득할 수 있다. 예를 들어, 요오드화메탄, 포름알데히드/팔라듐/수소, 포름알데히드/시아노수소화보론나트륨 등을 이용하여 티라민의 질소에 메틸기를 직접 도입하거나, 보다 바람직하게는 하기 반응식 1에 나타낸 바와 같이 티라민의 질소에 t-부틸옥시카르보닐기를 도입한 후 수소화리튬알루미늄 등으로 환원반응시켜 수득할 수 있다. 4- (2-methylaminoethyl) phenol of Formula 2 used in step (i) may be obtained by methylation of tyramine. For example, a methyl group is introduced directly into the nitrogen of tyramine using methane iodide, formaldehyde / palladium / hydrogen, sodium formaldehyde / boron hydrogen borohydride, or more preferably nitrogen of tyramine as shown in Scheme 1 below. It can be obtained by introducing a t -butyloxycarbonyl group into the compound, followed by reduction with lithium aluminum hydride.
[반응식 1][Reaction Scheme 1]
한편, 화학식 3의 3-(메틸설포닐)아크릴산은 하기 반응식 2에 나타낸 바와 같이, 프로피올릭산과 메틸티오금속, 바람직하게는 메틸티오나트륨을 반응시켜 하기 화학식 6의 3-(메틸티오)아크릴산을 수득한 다음 산화 반응시켜 수득할 수 있다. On the other hand, 3- (methylsulfonyl) acrylic acid of Chemical Formula 3 is reacted with propiolic acid and methylthiometal, preferably methylthio sodium, as shown in Scheme 2 below to give 3- (methylthio) acrylic acid of Chemical Formula 6 This can be obtained by an oxidation reaction.
[반응식 2]Scheme 2
[화학식 6][Formula 6]
상기 산화 반응에서 사용되는 산화제로는 과산화수소, 3-클로로퍼벤조산, 옥손 등이 있다. 바람직하게는 3-클로로퍼벤조산을 사용한다. Oxidizing agents used in the oxidation reaction include hydrogen peroxide, 3-chloroperbenzoic acid, oxone and the like. Preferably 3-chloroperbenzoic acid is used.
상기 단계 (i)에서는 하기 반응식 3에 나타낸 바와 같이, 화학식 2의 4-(2-메틸아미노에틸)페놀과 화학식 3의 3-(메틸설포닐)아크릴산을 아미드 결합 반응시켜 화학식 5의 N-(4-히드록시펜에틸)-N-메틸-3-(메틸설포닐)아크릴아미드를 합성한다. In step (i), as shown in the following Scheme 3, 4- (2-methylaminoethyl) phenol of the formula (2) and 3- (methylsulfonyl) acrylic acid of the formula (3) are subjected to an amide bond reaction to form N- ( 4-hydroxyphenethyl) -N -methyl-3- (methylsulfonyl) acrylamide is synthesized.
[반응식 3]Scheme 3
상기 아미드 결합 반응은 염산티오닐/염기 또는 옥시염화인/염기 존재하에서 수행될 수 있다. 이때 염기로는 유기염기와 무기염기 모두를 사용할 수 있는데, 예를 들어 유기 염기로는 트리에틸아민, 디이소프로필아민, 트리부틸아민 등, 무기염기로는 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 탄산수소나트륨 등을 사용할 수 있다. 또한 상기 결합 반응은 디사이클로헥실디카보이미드/디메틸아미노피리딘, 디사이클로헥실디카보이미드/1-하이드록시벤조트리아졸, 1-에틸-3-(3-디메틸아미노프로필)-카보디이미드 염산염/1-하이드록시벤조트리아졸, 1-에틸-3-(3- 디메틸아미노프로필)-카보디이미드 염산염/디메틸아미노피리딘 등의 존재하에서, 용매로 디클로로메탄, 테트라하이드로푸란, 디메틸포름아미드 등을 사용하여 수행될 수 있다. 가장 바람직하게는, 상기 결합 반응은 1-에틸-3-(3-디메틸아미노프로필)카보디이미드 염산염/디메틸아미노피리딘의 존재하에서 디메틸포름아미드를 용매로 사용하여 수행된다. 이때 반응온도는 상온이 가장 바람직하다. The amide linkage reaction can be carried out in the presence of thionyl hydrochloride / base or phosphorus oxychloride / base. At this time, both organic base and inorganic base may be used as the base. For example, triethylamine, diisopropylamine, tributylamine, etc. may be used as the organic base, and sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc. And sodium hydrogencarbonate can be used. In addition, the coupling reaction is dicyclohexyldicarbodiimide / dimethylaminopyridine, dicyclohexyldicarbodiimide / 1-hydroxybenzotriazole, 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide hydrochloride / In the presence of 1-hydroxybenzotriazole and 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide hydrochloride / dimethylaminopyridine, dichloromethane, tetrahydrofuran, dimethylformamide and the like are used as a solvent. Can be performed. Most preferably, the coupling reaction is carried out using dimethylformamide as solvent in the presence of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride / dimethylaminopyridine. The reaction temperature is most preferably at room temperature.
상기 단계 (ii)에서는 화학식 5의 N-(4-히드록시펜에틸)-N-메틸-3-(메틸설포닐)아크릴아미드와 화학식 4의 화합물을 결합 반응시켜 화학식 9의 (E)-N-메틸-N-[4-{(E)-3-메틸-4-(2-(2-메틸프로프-1-엔일)-1,3-[디치안]-2-일)부트-2-엔일옥시}펜에틸]-3-(메틸설포닐)아크릴아미드를 합성한다. In step (ii), N- (4-hydroxyphenethyl) -N -methyl-3- (methylsulfonyl) acrylamide of formula 5 and a compound of formula 4 are combined to react ( E ) -N of formula (9). -Methyl- N- [4-{( E ) -3-methyl-4- (2- (2-methylprop-1-enyl) -1,3- [dioxy] -2-yl) but-2 -Ynyloxy} phenethyl] -3- (methylsulfonyl) acrylamide is synthesized.
X가 히드록시기인 경우, 페놀기와 히드록시기의 결합 반응은 미츠노부(Mitsunobu) 조건[Organic Reactions, vol. 42, p 335)]을 사용하여 수행될 수 있다. 예를 들어 디이소프로필 아조디카르복실레이트, 디에틸 아조디카르복실레이트 등이 일반적으로 사용될 수 있고, 트리페닐포스핀과 트리부틸포스핀이 함께 사용될 수 있다. 반응온도는 0℃부터 가열 환류 온도까지 사용될 수 있는데, 상온에서 초음파를 이용하여 반응을 진행시키는 것이 가장 바람직하다.When X is a hydroxy group, the coupling reaction of the phenol group and the hydroxy group is performed under Mitsunobu conditions [ Organic Reactions , vol. 42, p 335)]. For example, diisopropyl azodicarboxylate, diethyl azodicarboxylate and the like can be generally used, and triphenylphosphine and tributylphosphine can be used together. The reaction temperature can be used from 0 ℃ to the heating reflux temperature, it is most preferable to proceed with the reaction using ultrasonic waves at room temperature.
상기 단계 (iii)에서는 화학식 9의 (E)-N-메틸-N-[4-{(E)-3-메틸-4-(2-(2-메틸프로프-1-엔일)-1,3-[디치안]-2-일)부트-2-엔일옥시}펜에틸]-3-(메틸설포닐)아크릴아미드를 탈보호 반응시켜 화학식 1의 메틸제람블론을 제조한다.In step (iii), ( E ) -N -methyl- N- [4-{( E ) -3-methyl-4- (2- (2-methylprop-1-enyl) -1, represented by Formula 9, Deprotection reaction of 3- [dithiane] -2-yl) but-2-enyloxy} phenethyl] -3- (methylsulfonyl) acrylamide to prepare methyl zelamblon of formula (1).
상기 디치안의 탈보호 반응은 트리플루오로아세틱산, 수은 수용액, t-부틸하이드로퍼옥사이드, 요오드화메탄/물/아세토니트릴, 3-클로로퍼벤조산/무수초산 등 을 사용하여 수행될 수 있다. 가장 바람직하게는 요오드화메탄/물/아세토니트릴을 사용하나, 이때 아세토니트릴은 테트라하이드로푸란, 다이옥산, 아세톤, 디클로로메탄, 초산에틸 등으로 대체할 수 있다. 반응 온도는 0℃부터 가열 환류온도까지 가능하며, 상온이 가장 바람직하다. The deprotection reaction of dithiane may be performed using trifluoroacetic acid, aqueous mercury solution, t -butylhydroperoxide, methane iodide / water / acetonitrile, 3-chloroperbenzoic acid / acetic anhydride, and the like. Most preferably methane iodide / water / acetonitrile is used, where acetonitrile can be replaced with tetrahydrofuran, dioxane, acetone, dichloromethane, ethyl acetate and the like. The reaction temperature can be from 0 ℃ to the heating reflux temperature, the room temperature is most preferred.
상기한 화학식 9 및 화학식 1의 화합물의 제조공정을 하기 반응식 5에 나타내었다.The process for preparing the compounds of Formula 9 and Formula 1 is shown in Scheme 5 below.
[반응식 5]Scheme 5
한편으로, 본 발명은 하기 화학식 4로 나타내는 신규 중간체에 관한 것이다.On the other hand, the present invention relates to a novel intermediate represented by the following formula (4).
[화학식 4][Formula 4]
상기 식에서, X는 히드록시기 또는 이탈기이다. 상기 이탈기로서는 클로라이드, 브로마이드, 메실, 또는 토실기가 바람직하다.Wherein X is a hydroxy group or leaving group. As the leaving group, a chloride, bromide, mesyl, or tosyl group is preferable.
다른 한편으로, 본 발명은 상기 화학식 4의 중간체의 제조방법에 관한 것으 로, 본 발명의 중간체의 제조방법은 On the other hand, the present invention relates to a method for preparing the intermediate of Formula 4, the method for preparing the intermediate of the present invention
(i) 하기 화학식 7의 2-(2-메틸프로페닐)-[1,3]-디치안과 하기 화학식 8의 2-메틸-4-(t-부틸디페닐실란일옥시)부트-2-엔-1-올을 결합 반응시키는 단계; 및(i) 2- (2-methylpropenyl)-[1,3] -dithiane of formula (7) and 2-methyl-4- ( t -butyldiphenylsilaneyloxy) but-2- of formula (8) Binding reaction of the en-1-ol; And
(ii) 임의로 히드록시기를 이탈기로 치환 반응시키는 단계를 포함한다. (ii) optionally reacting the hydroxy group with a leaving group.
[화학식 7][Formula 7]
[화학식 8][Formula 8]
상기 식에서, R1, R2 및 R3는 각각 독립적으로 알킬기 또는 아릴기이다.In the above formula, R 1 , R 2 and R 3 are each independently an alkyl group or an aryl group.
본 명세서에서 알킬기는 탄소수 1 내지 5개로 구성된 직쇄형 또는 분지형 탄화수소를 의미하며, 예를 들어, 메틸, 에틸, 프로필, 이소프로필, 부틸, 이소부틸, t-부틸 등이 포함되나 이에 한정되는 것은 아니다. In the present specification, an alkyl group means a straight or branched hydrocarbon having 1 to 5 carbon atoms, and examples thereof include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t -butyl, and the like. no.
아릴기는 단순 또는 융합 고리형이며 고리는 5 내지 15각형으로 이루어져 있는 불포화 탄화수소이다. 아릴기의 예로는 페닐 등이 포함되나 이에 한정되는 것은 아니다. The aryl group is a simple or fused cyclic and the ring is an unsaturated hydrocarbon consisting of 5 to 15 hexagons. Examples of the aryl group include, but are not limited to, phenyl and the like.
상기 단계 (i)에서 사용되는 화학식 7의 2-(2-메틸프로페닐)-[1,3]-디치안은 3-메틸크로톤알데히드와 1,3-프로판디치올을 산 촉매하에서 반응시켜 수득할 수 있 다. 이때 산 촉매로는 트리플루오로보론 에테르, 파라톨루엔설폰산, 황산, 캄포설폰산, 인산 등이 사용될 수 있다. 반응 온도는 -20℃ 내지 상온이 바람직하며, 반응 용매로는 테트라하이드로푸란, 다이옥산, 디클로로메탄 등이 사용될 수 있다. 디클로로메탄을 용매로 하고 트리플루오로보론 에테르를 산 촉매로 하여 -10℃에서 반응을 진행시키는 것이 가장 바람직하다. 2- (2-methylpropenyl)-[1,3] -dithiane of formula (7) used in step (i) is obtained by reacting 3-methylcrotonaldehyde with 1,3-propanedichiol under an acid catalyst. can do. In this case, as the acid catalyst, trifluoroboron ether, paratoluenesulfonic acid, sulfuric acid, camphorsulfonic acid, phosphoric acid, and the like may be used. The reaction temperature is preferably -20 ° C to room temperature, and tetrahydrofuran, dioxane, dichloromethane, or the like may be used as the reaction solvent. Most preferably, the reaction proceeds at -10 占 폚 with dichloromethane as solvent and trifluoroboron ether as acid catalyst.
한편, 화학식 8의 2-메틸-4-(t-부틸디페닐실란일옥시)부트-2-엔-1-올은 3-메틸-2-부텐-1-올에 실란 보호기를 도입한 후 히드록시기를 도입하여 수득할 수 있다. 실란 보호기의 도입은 알킬/아릴실릴할라이드와 촉매를 사용하여 수행될 수 있다. 촉매로는 이미다졸, 질산은, 피리딘 등이 사용될 수 있으며, 디아미노피리딘이 같이 사용될 수 있다. 반응 용매로는 테트라하이드로푸란, 디클로로메탄, 디메틸포름아미드 등이 사용될 수 있으며, 반응 온도는 -20℃ 내지 상온이 바람직하다. 디클로로메탄을 용매로 하고 이미다졸을 촉매로 하여 상온에서 반응을 진행시키는 것이 가장 바람직하다.Meanwhile, 2-methyl-4- ( t -butyldiphenylsilaneyloxy) but-2-en-1-ol of the formula (8) is a hydroxyl group after introducing a silane protecting group into 3-methyl-2-buten-1-ol It can be obtained by introducing. Introduction of silane protecting groups can be carried out using alkyl / arylsilyl halides and catalysts. As the catalyst, imidazole, silver nitrate, pyridine and the like can be used, and diaminopyridine can be used together. Tetrahydrofuran, dichloromethane, dimethylformamide and the like may be used as the reaction solvent, and the reaction temperature is preferably -20 ° C to room temperature. Most preferably, the reaction is carried out at room temperature using dichloromethane as a solvent and imidazole as a catalyst.
상기 단계 (i)에서 결합 반응은 수소화나트륨, n-부틸리튬, t-부틸리튬, sec-부틸리튬 등의 염기 존재 하에서, 테트라하이드로푸란, 디메틸포름아미드, 톨루엔 등을 용매로 사용하여 디치안의 음이온을 제조한 후, 화학식 8의 2-메틸-4-(t-부틸디페닐실란일옥시)부트-2-엔-1-올의 히드록시기가 이탈기로 치환된 화합물과 반응시켜 수행될 수 있다. 이때 반응 온도는 -78 내지 -20℃가 바람직하며, -78℃가 가장 바람직하다. In step (i), the coupling reaction is carried out using dihydrogen using tetrahydrofuran, dimethylformamide, toluene, etc. in the presence of a base such as sodium hydride, n -butyllithium, t -butyllithium, sec -butyllithium, or the like. After preparing an anion, the reaction may be performed by reacting a compound in which the hydroxyl group of 2-methyl-4- ( t -butyldiphenylsilaneyloxy) but-2-en-1-ol of Formula 8 is substituted with a leaving group. At this time, the reaction temperature is preferably -78 to -20 ℃, most preferably -78 ℃.
상기한 화학식 7, 화학식 8 및 화학식 4의 화합물의 제조공정을 하기 반응식 4에 나타내었다.Processes for preparing the compounds of Formula 7, Formula 8 and Formula 4 are shown in Scheme 4 below.
[반응식 4]Scheme 4
또 다른 한편으로, 본 발명은 하기 화학식 5, 화학식 7, 화학식 8, 또는 화학식 9로 나타내는 신규 중간체에 관한 것이다. On the other hand, the present invention relates to a novel intermediate represented by the following formula (5), (7), (8) or (9).
[화학식 5][Chemical Formula 5]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
상기 식에서, R1, R2 및 R3는 각각 독립적으로 알킬기 또는 아릴기, 바람직하 게는 메틸, 에틸, 프로필, 이소프로필, 부틸, 이소부틸, t-부틸, 또는 페닐이다. Wherein R 1 , R 2 and R 3 are each independently an alkyl or aryl group, preferably methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t -butyl, or phenyl.
[화학식 9][Chemical Formula 9]
본 발명에 따르면, 운향과의 일종인 글리코스미스 앙구스티폴리아(Glycosmis angustifolia)의 잎으로부터 추출에 의해 얻었던 메틸제람블론을 신규한 특정 중간체들을 이용하여 고수율 및 고순도로 용이하게 제조할 수 있다. According to the present invention, methylzelamblon obtained by extraction from the leaves of Glycosmis angustifolia , which is a kind of fragrance family, can be easily produced in high yield and high purity using novel specific intermediates.
이하, 실시예에 의해 본 발명을 보다 구체적으로 설명하고자 한다. 이들 실시예는 오직 본 발명을 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업자에게 있어서 자명하다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, it is obvious to those skilled in the art that the scope of the present invention is not limited to these examples.
실시예Example 1: ( One: ( EE )-3-() -3- ( 메틸티오Methylthio )아크릴산의 제조Production of Acrylic Acid
2N-수산화나트륨 수용액 39 mL에 프로피올릭산 5.2g을 천천히 가하고, 이 용액에 15% 메틸티오나트륨 수용액 35g을 천천히 가한 다음, 120℃에서 12 시간동안 가열 환류하였다. 0℃로 냉각한 후 진한 염산을 천천히 가하여 pH를 1로 맞추었다. 생성된 고체를 여과한 후 찬물로 세척하고 여액을 초산에틸로 추출하고 무수 황산마그네슘으로 건조한 후 감압 농축하여 연노란색 고체를 얻었다. 앞서 얻은 고체와 합친 후 크실렌 1,000 mL를 가하고 48시간 동안 가열 환류하였다. 크실렌을 완전히 제거한 후 초산에틸로 재결정하여 노란색 고체 화합물 5.6g (수율 65.05%)을 얻었다.5.2 g of propiolic acid was slowly added to 39 mL of 2N-sodium hydroxide aqueous solution, and 35 g of 15% aqueous methylthiosodium solution was slowly added thereto, followed by heating to reflux for 12 hours. After cooling to 0 ° C., concentrated hydrochloric acid was slowly added to adjust the pH to 1. The resulting solid was filtered, washed with cold water, the filtrate was extracted with ethyl acetate, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give a pale yellow solid. After combined with the solid obtained earlier, 1,000 mL of xylene was added and heated to reflux for 48 hours. The xylene was completely removed and recrystallized from ethyl acetate to give 5.6 g (yield 65.05%) of a yellow solid compound.
1H NMR (400MHz, DMSO-d 6 ) : δ=12.04(1H, s, -COOH), 7.71(1H, J=14.8Hz, -SCH=), 5.63(1H, J=14.8Hz, -SCH=CH-COOH), 2.34(3H,s, -SCH3) 1 H NMR (400 MHz, DMSO-d 6 ): δ = 12.04 (1H, s, -COO H ), 7.71 (1H, J = 14.8 Hz, -SC H =), 5.63 (1H, J = 14.8 Hz,- SCH = C H -COOH), 2.34 (3H, s, -SCH 3 )
13C NMR (100MHz, DMSO-d 6 ) : δ=166.16, 147.22, 114.35, 14.17 13 C NMR (100 MHz, DMSO-d 6 ): δ = 166.16, 147.22, 114.35, 14.17
실시예Example 2: ( 2: ( EE )-3-() -3- ( 메틸설포닐Methylsulfonyl )아크릴산의 제조Production of Acrylic Acid
2.02g의 상기 실시예 1에서 수득한 (E)-3-(메틸티오)아크릴산을 디클로로메탄 250 mL에 녹인 후 0℃로 냉각하였다. 그런 다음, 70% 3-클로로퍼벤조산 8.04g을 가한 후 12시간 동안 0℃에서 교반하였다. 그런 다음, 아황산수소나트륨 4g을 가하고 5시간 동안 교반한 후 여과하였다. 여액을 100 mL로 농축하고 생성된 고체를 여과한 다음, 여액을 농축하고 잔류물을 이소프로필에테르로 재결정하여 백색 고체 화합물 2.7g (수율 100%)을 얻었다.2.02 g of ( E ) -3- (methylthio) acrylic acid obtained in Example 1 was dissolved in 250 mL of dichloromethane and cooled to 0 ° C. Then, 8.04 g of 70% 3-chloroperbenzoic acid was added, followed by stirring at 0 ° C. for 12 hours. Then, 4 g of sodium hydrogen sulfite was added thereto, stirred for 5 hours, and filtered. The filtrate was concentrated to 100 mL and the resulting solid was filtered, the filtrate was concentrated and the residue was recrystallized from isopropyl ether to give 2.7 g (100% yield) of a white solid compound.
1H NMR (400MHz, DMSO-d 6 ) : δ=13.54(1H, s, -COOH), 7.64(1H, J=15.6Hz, -S(O)2CH=), 6.62(1H, J=15.6Hz, -OSCH=CH-COOH), 3.18(3H,s, -S(O)2CH3) 1 H NMR (400 MHz, DMSO-d 6 ): δ = 13.54 (1H, s, -COO H ), 7.64 (1H, J = 15.6 Hz, -S (O) 2 C H =), 6.62 (1H, J = 15.6 Hz, -OSCH = C H -COOH), 3.18 (3H, s, -S (O) 2 CH 3 )
13C NMR (100MHz, DMSO-d 6 ) : δ=165.17, 143.01, 132.19, 41.96 13 C NMR (100 MHz, DMSO-d 6 ): δ = 165.17, 143.01, 132.19, 41.96
실시예Example 3: 4-(2- 3: 4- (2- 메틸아미노에틸Methylaminoethyl )페놀 염산염의 제조Preparation of Phenolic Hydrochloride
티라민 10g을 디클로로메탄 100 mL에 현탁시키고 디-t-부틸디카보네이트 17.5g을 가한 다음, 2시간 동안 교반한 후 반응 혼합물을 감압 하에서 농축하였다. 잔류물을 무수 다이옥산 250 mL에 녹인 후 0℃로 냉각하였다. 수소화리튬알루미늄 13.8g을 가하고 2시간 동안 상온에서 교반한 후 90℃에서 24시간 가열하였다. 메탄올 10 mL를 가하여 반응을 중지시키고 더 이상 가스가 발생되지 않으면 메탄올 200 mL를 가하였다. 생성된 고체를 여과하고 여액에 진한 염산을 가하여 pH를 1로 맞추었다. 연속 추출장치를 이용하여 초산에틸로 추출한 후 초산에틸을 감압 농축하여 백색의 고체 화합물 10.2g (수율 93%)을 얻었다.10 g of tyramine was suspended in 100 mL of dichloromethane, 17.5 g of di-t-butyldicarbonate was added, followed by stirring for 2 hours, and then the reaction mixture was concentrated under reduced pressure. The residue was taken up in 250 mL of anhydrous dioxane and cooled to 0 ° C. 13.8 g of lithium aluminum hydride was added thereto, stirred at room temperature for 2 hours, and heated at 90 ° C. for 24 hours. 10 mL of methanol was added to stop the reaction and 200 mL of methanol was added when no gas was generated. The resulting solid was filtered and pH was adjusted to 1 by addition of concentrated hydrochloric acid to the filtrate. After extracting with ethyl acetate using a continuous extractor, ethyl acetate was concentrated under reduced pressure to give 10.2 g of a white solid compound (yield 93%).
1H NMR (400MHz, CD3OD) : δ=7.11(2H, dd , J=6.4, 1.6 Hz, phenyl), 6.77(2H, dd , J=6.4, 1.6Hz, aryl),3.19(2H, m, -CH2-), 2.89(2H, m, -CH2-), 2.70(3H,s, -NCH 3 ) 1 H NMR (400 MHz, CD 3 OD): δ = 7.11 (2H, dd , J = 6.4, 1.6 Hz, phenyl), 6.77 (2H, dd , J = 6.4, 1.6Hz, aryl), 3.19 (2H, m , -CH 2- ), 2.89 (2H, m, -CH 2- ), 2.70 (3H, s, -NC H 3 )
13C NMR (100MHz, CD3OD) : δ=156.45, 129.41, 126.64, 115.36, 50.39, 32.32, 31.12 13 C NMR (100 MHz, CD 3 OD): δ = 156.45, 129.41, 126.64, 115.36, 50.39, 32.32, 31.12
실시예Example 4: 4: NN -(4--(4- 히드록시펜에틸Hydroxyphenethyl )-) - NN -- 메틸methyl -3-(-3- ( 메틸설포닐Methylsulfonyl )) 아크릴아미드의Acrylamide 제조 Produce
실시예 3에서 수득한 4-(2-메틸아미노에틸)페놀 염산염 1.44g, 실시예 2에서 수득한 (E)-3-(메틸설포닐)아크릴산 1.15g, 및 디메틸아미노피리딘 93mg을 디메틸포름아미드 50 mL에 녹인 후 트리에틸아민 1.28 mL를 가하였다. 0℃로 냉각한 후 1-에틸-3-(3-디메틸아미노프로필)카보디이미드 염산염 1.16g을 가하고 상온에서 24시간 동안 교반하였다. 1M 염산 수용액을 가하여 pH를 5~6으로 맞춘 후 초산에틸로 추출하였다. 유기층을 무수 황산마그네슘으로 처리하여 건조하고 여과한 다음 여액을 감압 농축하였다. 잔류물을 실리카겔 컬럼크로마토그래피(초산에틸:헥산 = 2:1)하여 백색 고체 화합물 1.1g (수율 : 51%)을 얻었다. 1.44 g of 4- (2-methylaminoethyl) phenol hydrochloride obtained in Example 3, 1.15 g of ( E ) -3- (methylsulfonyl) acrylic acid obtained in Example 2, and 93 mg of dimethylaminopyridine were converted into dimethylformamide. After dissolving in 50 mL, 1.28 mL of triethylamine was added thereto. After cooling to 0 ° C., 1.16 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added and stirred at room temperature for 24 hours. 1M aqueous hydrochloric acid solution was added to adjust the pH to 5-6, and extracted with ethyl acetate. The organic layer was treated with anhydrous magnesium sulfate, dried, filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate: hexane = 2: 1) to obtain 1.1 g of a white solid compound (yield: 51%).
Cis-soid Cis -soid
1H NMR (400MHz, CDCl3) : δ=7.33(1H, d , J=14.4Hz, -SO2CH=CH-), 7.05(2H, d, J=8.4Hz, aryl), 6.79(2H, d, J=8.4Hz, aryl), 3.67(2H, t, J=7.2Hz, -CH2CH 2 N), 3.01(3H, s, -CH3), 2.91(3H, s, -CH 3 ), 2.81(2H, t, J=7.2Hz, -CH 2 CH 2 N) 1 H NMR (400 MHz, CDCl 3 ): δ = 7.33 (1H, d , J = 14.4 Hz, -SO 2 C H = CH-), 7.05 (2H, d, J = 8.4 Hz, aryl), 6.79 (2H , d, J = 8.4 Hz, aryl), 3.67 (2H, t, J = 7.2 Hz, -CH 2 C H 2 N), 3.01 (3H, s, -CH 3 ), 2.91 (3H, s, -C H 3 ), 2.81 (2H, t, J = 7.2 Hz, -C H 2 CH 2 N)
13C NMR (100MHz, CDCl3) : δ=162.82, 154.87, 139.57, 133.13, 129.86, 129.77, 115.55, 50.34, 42.40, 36.29, 31.60 13 C NMR (100 MHz, CDCl 3 ): δ = 162.82, 154.87, 139.57, 133.13, 129.86, 129.77, 115.55, 50.34, 42.40, 36.29, 31.60
Tran-soid Tran -soid
1H NMR (400MHz, CDCl3) : δ=6.93~6.89 (3H, m, aryl and vinyl), 6.77~6.73(3H, m, aryl and vinyl), 3.60(2H, t, J=6.0Hz, -CH2CH 2 N), 3.08(3H, s, -CH 3 ), 2.86(3H, s, -CH 3 ), 2.79(2H, t, J=6.0Hz, -CH 2 CH 2 N) 1 H NMR (400 MHz, CDCl 3 ): δ = 6.93-6.89 (3H, m, aryl and vinyl), 6.77-6.73 (3H, m, aryl and vinyl), 3.60 (2H, t, J = 6.0 Hz,- CH 2 C H 2 N), 3.08 (3H, s, -C H 3 ), 2.86 (3H, s, -C H 3 ), 2.79 (2H, t, J = 6.0 Hz, -C H 2 CH 2 N )
13C NMR (100MHz, CDCl3) : δ=163.52, 155.59, 138.22, 132.03, 130.31, 128.65, 116.24, 52.44, 42.47, 34.28, 33.61 13 C NMR (100 MHz, CDCl 3 ): δ = 163.52, 155.59, 138.22, 132.03, 130.31, 128.65, 116.24, 52.44, 42.47, 34.28, 33.61
실시예Example 5: 2-(2- 5: 2- (2- 메틸프로페닐Methylpropenyl )-[1,3]-)-[1,3]- 디치안의Dian 제조 Produce
3-메틸크로톤알데히드 6.7g을 디클로로메탄 30 mL에 녹인 후, 1,3-프로판디치올 8.6g을 가하고 -10℃로 냉각하였다. 그런 다음, 트리플루오로보론 에테르 용액 1 mL를 가하고 3시간 동안 교반하였다. 15% 수산화나트륨 수용액으로 유기층을 세척한 후 무수 황산마그네슘으로 건조하여 여과한 후, 여액을 감압 증류하여 무색의 액체 화합물인 2-(2-메틸프로페닐)-[1,3]-디치안 12.1g (수율 87.35%)을 얻었다.After dissolving 6.7 g of 3-methylcrotonaldehyde in 30 mL of dichloromethane, 8.6 g of 1,3-propanedithiol was added and cooled to -10 ° C. Then 1 mL of trifluoroboron ether solution was added and stirred for 3 hours. The organic layer was washed with 15% aqueous sodium hydroxide solution, dried over anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure to obtain 2- (2-methylpropenyl)-[1,3] -dicia 12.1 as a colorless liquid compound. g (yield 87.35%) was obtained.
1H NMR (400MHz, CDCl3) : δ=5.12(1H, =CH), 4.85(1H, d, J=10.0Hz, -SCHS-), 2.96~2.75(4H, m, -SCH 2 CH2CH 2 S-), 2.10~2.04(1H, m, -SCH2 CH 2CH2S-), 1.87~1.79(1H, m, -SCH2 CH 2CH2S-), 1.73(3H, d, J=1.6Hz, -CH3), 1.73(3H, d, J=1.2Hz, -CH3) 1 H NMR (400 MHz, CDCl 3 ): δ = 5.12 (1H, = C H ), 4.85 (1H, d, J = 10.0 Hz, -SC H S-), 2.96-2.75 (4H, m, -SC H 2 CH 2 C H 2 S-), 2.10-2.04 (1H, m, -SCH 2 C H 2 CH 2 S-), 1.87-1.79 (1H, m, -SCH 2 C H 2 CH 2 S-), 1.73 (3H, d, J = 1.6 Hz, -CH 3 ), 1.73 (3H, d, J = 1.2 Hz, -CH 3 )
13C NMR (100MHz, CDCl3) : δ=137.76, 121.19, 44.44, 30.61, 25.63, 25.00, 18.40 13 C NMR (100 MHz, CDCl 3 ): δ = 137.76, 121.19, 44.44, 30.61, 25.63, 25.00, 18.40
실시예Example 6: 2- 6: 2- 메틸methyl -4-(t--4- (t- 부틸디페닐실란일옥시Butyldiphenylsilaneyloxy )) 부트Boot -2-엔-1-올의 제조Preparation of 2-en-1-ol
3-메틸-2-부텐-1-올 1g을 디클로로메탄 5 mL에 녹인 후 t-부틸디페닐실릴클로라이드 3.51g 및 이미다졸 2.37g을 가하고 12시간 동안 교반하였다. 그런 다음 물을 가한 후 유기층을 분리하고 수층을 디클로로메탄으로 추출하였다. 유기층을 합하고 무수 황산마그네슘으로 건조하여 여과한 후 여액을 감압 농축하여 t-부틸디페닐-(3-메틸-부트-2-엔일옥시)실란을 얻었다.After dissolving 1 g of 3-methyl-2-buten-1-ol in 5 mL of dichloromethane, 3.51 g of t -butyldiphenylsilyl chloride and 2.37 g of imidazole were added and stirred for 12 hours. Then, water was added, the organic layer was separated, and the aqueous layer was extracted with dichloromethane. The organic layers were combined, dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain t -butyldiphenyl- (3-methyl-but-2-enyloxy) silane.
한편, 디클로로메탄 5 mL에 셀레늄디옥사이드 0.65g을 가하고 0℃로 냉각한 후 70% t-부틸하이드로퍼옥사이드 3 mL를 가하였다. 0℃에서 1시간 동안 교반한 후 상기 t-부틸디페닐-(3-메틸-부트-2-엔일옥시)실란을 가하고 상온에서 2일 동안 교반하였다. 디메틸설피드를 가하여 t-부틸하이드로퍼옥사이드를 환원한 후 15% 수산화나트륨 수용액을 가하였다. 그런 다음 디클로로메탄으로 추출하고 무수 황산마그네슘으로 건조한 후 여과하여 여액을 감압 농축하였다. 잔류물을 컬럼크로마토그래피(초산에틸:헥산 = 1:5)하여 액체 화합물 2.01g (수율 : 51%)을 얻었다.Meanwhile, 0.65 g of selenium dioxide was added to 5 mL of dichloromethane, cooled to 0 ° C., and 3 mL of 70% t -butylhydroperoxide was added thereto. After stirring for 1 hour at 0 ° C., the t -butyldiphenyl- (3-methyl-but-2-enyloxy) silane was added and stirred at room temperature for 2 days. Dimethyl sulfide was added to reduce t -butylhydroperoxide, followed by addition of 15% aqueous sodium hydroxide solution. Then, the mixture was extracted with dichloromethane, dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (ethyl acetate: hexane = 1: 5) to obtain 2.01 g of a liquid compound (yield: 51%).
1H NMR (400MHz, CDCl3) : δ=7.74~7.71(4H, m, phenyl), 7.47~7.39(6H, m, phenyl), 5.66(1H, m, =CH), 4.31(2H, d, J=6.4Hz, -CH 2 OTBDPS), 3.98(2H, s, -CH 2 OH), 1.08(9H, s, t-butyl) 1 H NMR (400 MHz, CDCl 3 ): δ = 7.74 ~ 7.71 (4H, m, phenyl), 7.47 ~ 7.39 (6H, m, phenyl), 5.66 (1H, m, = C H ), 4.31 (2H, d , J = 6.4 Hz, -C H 2 OTBDPS), 3.98 (2H, s, -C H 2 OH), 1.08 (9H, s, t -butyl)
13C NMR (100MHz, CDCl3) : δ=136.26, 135.65, 133.88, 129.65, 127.69, 124.87, 68.20, 60.81, 26.88, 19.20, 13.80 13 C NMR (100 MHz, CDCl 3 ): δ = 136.26, 135.65, 133.88, 129.65, 127.69, 124.87, 68.20, 60.81, 26.88, 19.20, 13.80
실시예Example 7: 3- 7: 3- 메틸methyl -4-[2-(2--4- [2- (2- 메틸프로페닐Methylpropenyl )-[1,3])-[1,3] 디치안Dian -2-일]-2 days] 부트Boot -2-엔-1-올의 제조Preparation of 2-en-1-ol
상기 실시예 6에서 수득한 2-메틸-4-(t-부틸디페닐실란일옥시)부트-2-엔-1-올 6.02g을 무수 디클로로메탄 60 mL에 녹인 후 -20℃로 냉각하였다. 트리에틸아민 3.45 mL와 디메틸아미노피리딘 108mg을 가한 후 파라톨루엔설포닐클로라이드 4.38g을 가하였다. 6시간 동안 교반하고 브롬화리튬 4.6g을 테트라하이드로푸란 60 mL에 녹여 천천히 가하였다. 0℃에서 2시간 동안 교반하고 물을 가한 후 유기층을 분리하고 수층을 디에틸에테르로 추출하였다. 그런 다음 유기층을 합하고 무수 황산마그네슘으로 건조하고 여과한 후 여액을 감압 농축하여 (4-브로모-3-메틸-부트-2-엔일옥시)-t-부틸디페닐실란을 얻었다.6.02 g of 2-methyl-4- ( t -butyldiphenylsilaneyloxy) but-2-en-1-ol obtained in Example 6 was dissolved in 60 mL of anhydrous dichloromethane, and cooled to -20 ° C. 3.45 mL of triethylamine and 108 mg of dimethylaminopyridine were added followed by 4.38 g of paratoluenesulfonyl chloride. After stirring for 6 hours, 4.6 g of lithium bromide was dissolved in 60 mL of tetrahydrofuran and added slowly. After stirring for 2 hours at 0 ° C., water was added, the organic layer was separated, and the aqueous layer was extracted with diethyl ether. The organic layers were then combined, dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure to afford (4-bromo-3-methyl-but-2-enyloxy) -t -butyldiphenylsilane.
실시예 5에서 수득한 2-(2-메틸프로페닐)-[1,3]디치안 5.94g을 무수 테트라하이드로푸란 20 mL에 녹이고 -78℃로 냉각하였다. 1.7M의 t-부틸리튬 테트라하이드로푸란 용액 60 mL를 천천히 가하였다. -20℃에서 2시간 동안 교반한 후 다시 -78℃로 냉각하였다. 그런 다음 상기 (4-브로모-3-메틸-부트-2-엔일옥시)-t-부틸디페닐실란 7 g을 20 mL의 무수 테트라하이드로푸란에 녹인 용액을 천천히 가하였다. 2시간 동안 -78℃에서 교반한 후 -40℃에서 12시간 동안 교반하였다. 그런 다음 물을 가하여 반응을 중지하고 상온에서 2시간 동안 교반하였다. 물과 디클로로메탄을 가하고 1시간 동안 교반한 다음 유기층을 분리한 후 수층을 디클로로메탄으로 추출하였다. 유기층을 합친 후 무수 황산마그네슘으로 건조하여 여과하고 여액을 감압 농축하였다. 잔류물에 1M 테트라부틸암모늄플로라이드/테트라하이드로푸란 용액 30 mL를 가하고 6시간 동안 상온에서 교반하였다. 물을 가한 후 수층을 디클로로메탄으로 추출하였다. 유기층을 무수 황산마그네슘으로 건조하여 여과하고 여액을 감압 농축하였다. 컬럼크로마토그래피(초산에틸:헥산 = 1:5)하여 액체 화합물 3.65g (수율 : 80%) 을 얻었다.5.94 g of 2- (2-methylpropenyl)-[1,3] dithiane obtained in Example 5 was dissolved in 20 mL of anhydrous tetrahydrofuran and cooled to -78 ° C. 60 mL of 1.7 M t -butyllithium tetrahydrofuran solution was slowly added. After stirring at −20 ° C. for 2 hours, the mixture was cooled to −78 ° C. again. Then a solution of 7 g of (4-bromo-3-methyl-but-2-enyloxy) -t -butyldiphenylsilane in 20 mL of anhydrous tetrahydrofuran was slowly added. Stir at -78 ° C for 2 hours and then at -40 ° C for 12 hours. Then water was added to stop the reaction and stirred for 2 hours at room temperature. Water and dichloromethane were added, the mixture was stirred for 1 hour, the organic layer was separated, and the aqueous layer was extracted with dichloromethane. The organic layers were combined, dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. 30 mL of 1M tetrabutylammonium fluoride / tetrahydrofuran solution was added to the residue, followed by stirring at room temperature for 6 hours. After adding water, the aqueous layer was extracted with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. Column chromatography (ethyl acetate: hexane = 1: 5) gave 3.65 g (yield: 80%) of a liquid compound.
1H NMR (400MHz, CDCl3) : δ=5.52(1H, m, =CH), 5.47(1H, m, =CH), 4.13(2H, d, J=6.8Hz, -CH 2 OH), 2.90~2.75(4H, m, -SCH 2 CH2CH 2 S-), 2.75(2H, s, -CH 2C(S)2), 2.01~1.84(2H, m, -SCH2 CH 2CH2S-),1.74(3H, s, -CH 3 ), 1.74(3H, s, -CH 3 ), 1.73 (3H, s, -CH 3 ) 1 H NMR (400 MHz, CDCl 3 ): δ = 5.52 (1H, m, = C H ), 5.47 (1H, m, = C H ), 4.13 (2H, d, J = 6.8 Hz, -C H 2 OH ), 2.90-2.75 (4H, m, -SC H 2 CH 2 C H 2 S-), 2.75 (2H, s, -C H 2 C (S) 2 ), 2.01-1.84 (2H, m, -SCH 2 C H 2 CH 2 S-), 1.74 (3H, s, -C H 3 ), 1.74 (3H, s, -C H 3 ), 1.73 (3H, s, -C H 3 )
13C NMR (100MHz, CDCl3) : δ=138.56, 134.52, 129.53, 127.91, 59.22, 52.68, 50.20, 27.83,27.59, 19.33, 18.12 13 C NMR (100 MHz, CDCl 3 ): δ = 138.56, 134.52, 129.53, 127.91, 59.22, 52.68, 50.20, 27.83,27.59, 19.33, 18.12
실시예Example 8: ( 8: ( EE )-) - NN -- 메틸methyl -- NN -[4-{(-[4-{( EE )-3-) -3- 메틸methyl -4-(2-(2--4- (2- (2- 메틸프로프Methylprop -1-엔일)-1,3-[-1-enyl) -1,3- [ 디치안Dian ]-2-일)]-2 days) 부트Boot -2--2- 엔일옥시Nyloxy }} 펜에틸Phenethyl ]-3-(] -3- ( 메틸설포닐Methylsulfonyl )) 아크릴아미드의Acrylamide 제조 Produce
실시예 7에서 수득한 3-메틸-4-[2-(2-메틸프로페닐)-[1,3]디치안-2-일]부트- 2-엔-1-올 3.646g, 실시예 4에서 수득한 N-(4-히드록시펜에틸)-N-메틸-3-(메틸설포닐)아크릴아미드 4.4g, 및 트리페닐포스핀 5.55g을 테트라하이드로푸란 100 mL에 녹였다. 그런 다음 디이소프로필 아조디카르복실레이트(DIAD) 3.7g을 가한 후 3시간 동안 초음파 처리하였다. 용매를 감압 농축한 후 컬럼크로마토그래피(초산에틸:헥산 = 2:1)하여 액체 화합물 4.5g (수율 : 61%)을 얻었다.3.646 g of 3-methyl-4- [2- (2-methylpropenyl)-[1,3] dioxy-2-yl] but-2-en-1-ol obtained in Example 7, Example 4 4.4 g of N- (4-hydroxyphenethyl) -N -methyl-3- (methylsulfonyl) acrylamide and 5.55 g of triphenylphosphine obtained in the above were dissolved in 100 mL of tetrahydrofuran. Then, 3.7 g of diisopropyl azodicarboxylate (DIAD) was added and sonicated for 3 hours. The solvent was concentrated under reduced pressure, and then column chromatography (ethyl acetate: hexane = 2: 1) gave 4.5 g of a liquid compound (yield: 61%).
Cis-soid + Tran-soid Cis -soid + Tran -soid
1H NMR (400MHz, CDCl3) : δ=7.30~6.79(6H, m ,aryl and vinyl), 5.55(1H, m, vinyl), 5.45(1H, br.s, vinyl), 4.50(1H, m, -CH 2 O), 3.0~2.7(11H, -CH 2 N, -NCH 3 , S-CH 2 -, -CH 2 CH 2 -), 12.0~1.8(2H, S-CH2CH 2 CH2S-), 1.91(3H, s, -CH 3 ), 1.78(3H, s, -CH 3 ), 1.72(3H, s, -CH 3 ) 1 H NMR (400 MHz, CDCl 3 ): δ = 7.30 ~ 6.79 (6H, m , aryl and vinyl), 5.55 (1H, m, vinyl), 5.45 (1H, br.s, vinyl), 4.50 (1H, m , -CH 2 O), 3.0-2.7 (11H, -C H 2 N, -NC H 3 , SC H 2- , -C H 2 C H 2- ), 12.0-1.8 (2H, S-CH 2 C H 2 CH 2 S-), 1.91 (3H, s, -C H 3 ), 1.78 (3H, s, -C H 3 ), 1.72 (3H, s, -C H 3 )
Cis-soid Cis -soid
13C NMR (100MHz, CDCl3) : δ=162.31, 157.52, 138.71, 138.69, 135.84, 133.20, 13033, 129.64, 127.75, 125.81, 114.88, 64.79, 52.51, 50.65, 42.49, 36.48, 32.50, 27.83, 27.58, 25.25, 19.41, 18.47 13 C NMR (100 MHz, CDCl 3 ): δ = 162.31, 157.52, 138.71, 138.69, 135.84, 133.20, 13033, 129.64, 127.75, 125.81, 114.88, 64.79, 52.51, 50.65, 42.49, 36.48, 32.50, 27.83, 27.58, 27.58, 25.25, 19.41, 18.47
Tran-soid Tran -soid
13C NMR (100MHz, CDCl3) : δ=162.85, 157.89, 139.49, 138.61, 135.90, 132.31, 130.02, 129.16, 127.79, 125.65, 115.20, 64.79, 52.19, 50.14, 42.27, 34.22, 33.92, 27.83, 27.58, 25.25, 19.41, 18.47 13 C NMR (100 MHz, CDCl 3 ): δ = 162.85, 157.89, 139.49, 138.61, 135.90, 132.31, 130.02, 129.16, 127.79, 125.65, 115.20, 64.79, 52.19, 50.14, 42.27, 34.22, 33.92, 27.83, 27.58, 27.58 25.25, 19.41, 18.47
실시예Example 9: 9: 메틸제람블론의Methylzelamblon 제조 Produce
실시예 8에서 수득한 (E)-N-메틸-N-[4-{(E)-3-메틸-4-(2-(2-메틸프로프-1-엔일)-1,3-[디치안]-2-일)부트-2-엔일옥시}펜에틸]-3-(메틸설포닐)아크릴아미드 4g을 아세토니트릴 110 mL에 녹인 후 물 40 mL를 가하였다. 요오드화메탄 20 mL를 가하고 상온에서 12시간 동안 교반하였다. 감압 농축하여 요요도화메탄과 아세토니트릴을 제거하고 디클로로메탄으로 추출한 후 무수황산마그네슘으로 건조하여 여과하고 여액을 감압 농축하였다. 컬럼크로마토그래피(초산에틸:헥산 = 3:1)하여 백색의 고체 화합물 1.77g (수율 : 54%)을 얻었다.( E ) -N -methyl- N- [4-{( E ) -3-methyl-4- (2- (2-methylprop-1-enyl) -1,3- [obtained in Example 8 4 g of dioxy] -2-yl) but-2-enyloxy} phenethyl] -3- (methylsulfonyl) acrylamide was dissolved in 110 mL of acetonitrile and 40 mL of water was added thereto. 20 mL of methane iodide was added and stirred at room temperature for 12 hours. Concentrated under reduced pressure to remove methane iodide and acetonitrile, extracted with dichloromethane, dried over anhydrous magnesium sulfate and filtered, and the filtrate was concentrated under reduced pressure. Column chromatography (ethyl acetate: hexane = 3: 1) gave 1.77 g (yield: 54%) of white solid compounds.
Cis-soid Cis -soid
1H NMR (400MHz, CDCl3) : δ=7.31(1H, d, J=14.4), 7.27(1H, d, J=14.4Hz), 7.07(2H, d, J=8.8Hz), 6.79(2H, J=8.8Hz), 6.07(1H, t, J=1.2Hz), 5.53(1H, m), 4.51(1H, d, J=6.4Hz), 3.59(2H, t, J=7.2Hz), 3.10(2H, brs), 2.97(3H, s), 2.95(3H, s), 2.78(2H, t, J=6.4Hz), 2.10(3H, br s), 1.84(3H, br s), 1.70(3H, br s) 1 H NMR (400 MHz, CDCl 3 ): δ = 7.31 (1H, d, J = 14.4), 7.27 (1H, d, J = 14.4 Hz), 7.07 (2H, d, J = 8.8 Hz), 6.79 (2H , J = 8.8 Hz), 6.07 (1H, t, J = 1.2 Hz), 5.53 (1H, m), 4.51 (1H, d, J = 6.4 Hz), 3.59 (2H, t, J = 7.2 Hz), 3.10 (2H, br s), 2.97 (3H, s), 2.95 (3H, s), 2.78 (2H, t, J = 6.4 Hz), 2.10 (3H, br s), 1.84 (3H, br s), 1.70 (3H, br s)
13C NMR (100MHz, CDCl3) : δ=198.13, 162.29, 156.5, 157.5, 139.5, 135.2, 133.3, 130.5, 129.7, 124.3, 122.8, 114.9, 64.7, 55.0, 50.6, 42.5, 36.5, 32.5, 27.7, 20.8, 17.0 13 C NMR (100 MHz, CDCl 3 ): δ = 198.13, 162.29, 156.5, 157.5, 139.5, 135.2, 133.3, 130.5, 129.7, 124.3, 122.8, 114.9, 64.7, 55.0, 50.6, 42.5, 36.5, 32.5, 27.7, 20.8, 17.0
Tran-soid Tran -soid
1H NMR (400MHz, CDCl3) : δ=6.69~6.95(2H, m), 6.85~6.78(2H, m), 6.07(1H, t, J=1.2Hz), 5.53(1H, m), 4.50(d , J=6.4Hz), 3.55(2H, J=6.4Hz), 3.10(2H, br s), 3.00(3H, s), 2.76(2H,t, J=6.4Hz), 2.10(3H, br s), 1.84(3H, br s), 1.70(3H, br s) 1 H NMR (400 MHz, CDCl 3 ): δ = 6.69 to 6.95 (2H, m), 6.85 to 6.68 (2H, m), 6.07 (1H, t, J = 1.2 Hz), 5.53 (1H, m), 4.50 (d, J = 6.4 Hz), 3.55 (2H, J = 6.4 Hz), 3.10 (2H, br s), 3.00 (3H, s), 2.76 (2H, t, J = 6.4 Hz), 2.10 (3H, 1.84 (3H, br), 1.70 (3H, br)
13C NMR (100MHz, CDCl3) : δ=198.11, 162.85, 157.9, 156.5, 138.6, 135.2, 132.4, 130.0, 129.2, 124.2, 122.8, 115.2, 64.7, 55.0, 52.2, 42.5, 34.2, 34.0, 27.7, 20.8, 17.0 13 C NMR (100 MHz, CDCl 3 ): δ = 198.11, 162.85, 157.9, 156.5, 138.6, 135.2, 132.4, 130.0, 129.2, 124.2, 122.8, 115.2, 64.7, 55.0, 52.2, 42.5, 34.2, 34.0, 27.7, 20.8, 17.0
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080011647A KR101176892B1 (en) | 2008-02-05 | 2008-02-05 | Method of preparing methylgerambullone and intermediates therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080011647A KR101176892B1 (en) | 2008-02-05 | 2008-02-05 | Method of preparing methylgerambullone and intermediates therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090085808A KR20090085808A (en) | 2009-08-10 |
KR101176892B1 true KR101176892B1 (en) | 2012-08-27 |
Family
ID=41205627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080011647A KR101176892B1 (en) | 2008-02-05 | 2008-02-05 | Method of preparing methylgerambullone and intermediates therefor |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101176892B1 (en) |
-
2008
- 2008-02-05 KR KR1020080011647A patent/KR101176892B1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Fortschritte der Chemie organischer Naturstoffe. Progress in the chemistry of organic natural products, Vol. 80, pp.187~219 (2000.). |
Also Published As
Publication number | Publication date |
---|---|
KR20090085808A (en) | 2009-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2004099149A1 (en) | Process for producing 2-chloro-5-fluoro-3-substituted pyridine or a salt thereof | |
EP1806338B1 (en) | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof | |
WO2013078559A1 (en) | Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene | |
WO1986002923A1 (en) | Process for preparing bicyclo ad3.3.0 bdoctenes | |
CN108473454B (en) | A process for the preparation of formula (1) and intermediates therefor | |
KR101176892B1 (en) | Method of preparing methylgerambullone and intermediates therefor | |
JP2015199674A (en) | Method of producing 1,3,4,5-tetracaffeoylquinic acid and intermediate compound | |
WO2000010986A1 (en) | Process for the preparation of (2r, 3s)-3-amino-1,2-oxirane | |
US11731930B2 (en) | Processes for preparing a (1,2-dimethyl-3-methylenecyclopentyl)acetate compound and (1,2-dimethyl-3-methylenecyclopentyl)acetaldehyde | |
US4094886A (en) | Process for producing allyl alcohol derivatives useful in prostaglandin synthesis | |
US4395561A (en) | Synthesis of 3-hydroxyoxetane | |
JP2022188579A (en) | Production method of preparing 2-(1,5,5-trimethyl-2-cyclopentenyl)ethyl=acetate | |
WO2006109570A1 (en) | Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate | |
KR20090112980A (en) | Method of preparing methylisogerambullone and intermediates therefor | |
JP7183476B2 (en) | Compound manufacturing method | |
JP4800933B2 (en) | Process for producing cyclopropane monoacetal derivative and its intermediate | |
JP4667589B2 (en) | Method for producing 2,4-dihydroxypyridine | |
KR100802531B1 (en) | Process for the manufacture of 4-o-protected-d-erythrose | |
EP0464218B1 (en) | Process for producing isoxazole derivative | |
JPWO2005095317A1 (en) | Method for producing halogenated unsaturated carbonyl compound | |
KR100502833B1 (en) | Improved preparation method of simvastatin and their intermediates | |
JP2022110339A (en) | METHOD FOR PRODUCING α-(MERCAPTOMETHYL) ACRYLATE | |
KR101052788B1 (en) | Novel Intermediates of Moracin P Compounds and Moracin O Compounds, Methods of Making Intermediates thereof, and Methods of Making Moracin P Compounds and Moracin O Compounds Using the Intermediates | |
JP2008174452A (en) | Method for producing 2,2-dichloro-12-(4-halophenyl)dodecanoic acid salt | |
JPWO2003035605A1 (en) | Novel compound and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150813 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160802 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |